Free with your TV subscription. More Information and FAQ NOW: Washington Journal NOW: KCC "HRSA Administrator Thomas Engels on U.S. Health Care Policy' Hudson Institute's Miles Yu discusses President ...
LDE-paclitaxel in second or later lines in advanced pancreatic cancer: A phase I trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results